EUVIMED · CrossrefZeitschrift
Pharmaceutical Science Advances
ISSN 2773-2169 · Elsevier BV
Neueste Artikel
Convergence of computer-aided drug discovery and artificial intelligence: Towards next-generation therapeutics
Graminoides A-D, antibacterial cyclic octaketides from the desert-derived Streptomyces
Metabolomic profiling of Musanga cecropioides leaf extract reveals cytotoxic mechanisms in MCF-7 breast cancer cells
Computational screening of Sophora flavescens phytochemicals as potential aromatase inhibitors: Molecular docking, ADMET, Network pharmacology, Molecular dynamics simulation, and DFT studies
Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy
Breaking through the radiation dilemma: development and clinical translation of anti-radiation drugs
NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL
The bidirectional interface between oral drug and the gut microbiome: Implications for drug delivery
Recent advances in chemiluminescence probes for Tumor microenvironment with applications in cancer diagnosis and therapy
Qualitative and quantitative standardisation of Epilobium angustifolium L. leaves according to Pharmacopoeial requirements
Unleashing the power of DNA-encoded libraries for challenging targets in drug discovery
Next-generation Janus kinase inhibitors: Integrating synthetic innovation, structural biology, and computational design for precision drug discovery
Toxicity of nanostructures in drug delivery applications
Functional identification of key enzymes in calycosin biosynthesis in Astragalus membranaceus and establishment of heterologous expression system
Artificial intelligence-driven discovery of coumarin-based therapeutics: Revolutionizing target identification and validation
Uncovering a photoprotective polysaccharide from Gentiana dahurica via systematic fractionation
Fufang Huangbo Formula mitigates myeloproliferative neoplasms by activating p53/p21 signaling axis and inhibiting STAT3 and NF-κB signaling pathways
Repurposing radiopharmaceutical carriers for targeted drug delivery and theranostics: A translational framework
Pharmaceutical development of composition of effervescent tablets with acetylsalicylic acid, paracetamol, and ascorbic acid
Discovery of novel Kir4.1 inhibitors based on serdemetan with potential therapy for glioblastoma-depression comorbidity
Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib
Bio-based nanomaterials in drug delivery: An updated review
Recent advances in HER2-targeted inhibitors for cancer therapy
BGC1201: A potent allosteric SHP2 inhibitor with broad antitumor activity in lung, pancreatic, and esophageal cancer xenografts
Calcium overload-induced apoptosis in cancer cells: ER-mitochondria crosstalk and therapeutic implications
Recent advances in the bioanalysis of acylcarnitines: Methodologies, challenges, and clinical perspectives
In vivo immune cell engineering from bench to clinical reality
A visualizable mitochondrial-targeted Chlorambucil prodrug for enhancing anti-hepatoma efficacy
Co-assembly of dipeptide and hydrophobic drug in hyaluronic acid through Schiff base reaction for the treatment of osteoarthritis
The gut-lung axis and viral pneumonia: Unrevealing the gut microbiota
EUVIMED